Three-quarters of UK IT leaders have no real AI governance. For regulated firms, that is not negligence — it is a regulatory violation waiting to be discovered. Trovix exists to make that discovery impossible.
Read more: AI governance without visibility is just liability waiting
Capitol Hill's refusal to grant antitrust exemptions for AI safety collaboration sounds like a US problem. It is not. UK regulated firms are being left in legal limbo, forced to buy from vendors whose safety practices remain unaudited and whose collaboration on existential risks is actively discoura
Read more: Antitrust stalling AI safety won't protect UK firms
AI vendors are lobbying for antitrust exemptions to collaborate on safety. They are asking the wrong question. UK regulated firms must stop accepting vendor opacity dressed as regulatory necessity.
Ema's $77M Series B proves AI agents can automate repetitive work at scale. That's not the same as saying they can replace professional judgment — and regulated firms that treat them as such will face FCA and SRA scrutiny.
Read more: AI agents won't save you from doing the work right
The UK's £100M AI procurement scheme will create real business for UK vendors. But regulated firms cannot afford to buy the same tools the public sector does, because the public sector does not yet know what it will actually demand from them.
Read more: UK's £100M AI bet won't work without governance first
Washington's stumbling approach to AI regulation is no excuse for UK firms to deploy untested AI agents without governance controls. The real lesson from the American mess is simpler: regulated firms must build their own guardrails now.
Read more: Regulatory chaos is not an excuse for reckless deployment
AIG's warning that AI data centres are exhausting insurer capacity misses the real problem: UK firms lack the frameworks to assess these risks properly. Fixing intake discipline matters more than buying smarter algorithms.
Read more: UK Insurers Face Hard Limits on AI Risk, Not Just Capacity